Crossject - Asset Resilience Ratio

Latest as of June 2022: 1.31%

Crossject (ALCJ) has an Asset Resilience Ratio of 1.31% as of June 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check asset allocation strategy of Crossject to assess the company's strategic physical and investment asset allocation.

Liquid Assets

€362.00K

≈ $423.22K USD Cash + Short-term Investments

Total Assets

€27.66 Million

≈ $32.33 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2021)

This chart shows how Crossject's Asset Resilience Ratio has changed over time. See Crossject balance sheet independence to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Crossject's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see ALCJ market cap.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€181.00K	0.65%
Short-term Investments	€181.00K	0.65%
Total Liquid Assets	€362.00K	1.31%

Asset Resilience Insights

Limited Liquidity: Crossject maintains only 1.31% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company maintains a balanced mix of cash and short-term investments.

Crossject Industry Peers by Asset Resilience Ratio

Compare Crossject's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Pegavision TW:6491	Medical Instruments & Supplies	17.14%
Ansell Ltd AU:ANN	Medical Instruments & Supplies	7.53%
Nanosonics Ltd AU:NAN	Medical Instruments & Supplies	46.84%
SDI Ltd AU:SDI	Medical Instruments & Supplies	3.36%
Austco Healthcare Ltd AU:AHC	Medical Instruments & Supplies	15.90%
Osteopore Ltd AU:OSX	Medical Instruments & Supplies	22.60%
Nyxoah BR:NYXH	Medical Instruments & Supplies	12.40%
Ocumetics Technology Corp V:OTC	Medical Instruments & Supplies	0.00%

Annual Asset Resilience Ratio for Crossject (2014–2021)

The table below shows the annual Asset Resilience Ratio data for Crossject.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2021-12-31	0.98%	€308.00K ≈ $360.08K	€31.52 Million ≈ $36.86 Million	+0.12pp
2020-12-31	0.86%	€288.42K ≈ $337.19K	€33.59 Million ≈ $39.27 Million	+0.02pp
2019-12-31	0.84%	€205.98K ≈ $240.81K	€24.49 Million ≈ $28.64 Million	+0.25pp
2018-12-31	0.59%	€118.30K ≈ $138.31K	€20.16 Million ≈ $23.57 Million	-1.27pp
2017-12-31	1.86%	€329.16K ≈ $384.82K	€17.72 Million ≈ $20.71 Million	+1.26pp
2016-12-31	0.60%	€85.68K ≈ $100.17K	€14.25 Million ≈ $16.66 Million	-3.48pp
2015-12-31	4.08%	€566.17K ≈ $661.91K	€13.88 Million ≈ $16.23 Million	+3.56pp
2014-12-31	0.52%	€95.68K ≈ $111.86K	€18.37 Million ≈ $21.48 Million	--

pp = percentage points

About Crossject

PA:ALCJ France Medical Instruments & Supplies

Market Cap

$117.41 Million

€100.42 Million EUR

Market Cap Rank

#19177 Global

#288 in France

Share Price

€1.89

Change (1 day)

-0.74%

52-Week Range

€1.40 - €2.69

All Time High

€10.40